Clinical Trials Logo

Hernia clinical trials

View clinical trials related to Hernia.

Filter by:

NCT ID: NCT05240586 Active, not recruiting - Clinical trials for Cervical Disc Herniation

Pharmacopuncture Therapy for Cervical Disc Herniation: A Pilot Study

Start date: April 20, 2022
Phase: N/A
Study type: Interventional

This is pilot study for a 3-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy, acupunture therapy and physical therapy, medication(prn) for cervical disc herniation.

NCT ID: NCT05231759 Active, not recruiting - Clinical trials for Lumbar Disc Herniation

Efficacy of Navigable Percutaneous Plasma Disc Decompression Device (L'DISQ) in Patients With Severe Lumbar Disc Herniation

L'DISQ
Start date: March 1, 2009
Phase:
Study type: Observational [Patient Registry]

This study aims to assess the clinical outcome of percutaneous disc decompression using the L'DISQ in patients with severe lumbar disc herniation (LDH).

NCT ID: NCT05105360 Active, not recruiting - Petersen's Hernia Clinical Trials

Prevention of Petersen's Hernia After Laparoscopic Gastrectomy

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

- Aim of this study To compare the cases underwent operation to treat intestinal obstruction caused by Peterson hernia within 3 years after laparoscopic gastrectomy between closure method and Mefix methods. - Primary end point: The cases underwent operation to treat intestinal obstruction caused by Peterson hernia within 3 years after laparoscopic gastrectomy was not- inferior between Closure and MEFIX. - Secondary endpoint: Procedures' times (minutes), bleeding, Hospital stays (days) Occurrence of postoperative small bowel obstruction within 30 days after surgery, Short-term complications within 30 days after surgery, Occurrence of Petersen's Hernia according to the use of anti-adhesion agents, anastomotic methods, CLOSURE or MEFIX previous surgical suture condition, hernia degree, and bowel condition (strangulation, perforation) at the timing of emergent operation for treatment of Petersen's Hernia obstructions

NCT ID: NCT05091853 Active, not recruiting - Surgery Clinical Trials

Laparscopic Inguinal Hernia Repair - Does the Choice of Self-fixated Mesh Matter?

Start date: May 9, 2021
Phase: N/A
Study type: Interventional

Self-fixed mesh and postoperative pain after laparoscopic inguinal hernia surgery, a randomized clinical trial

NCT ID: NCT05072171 Active, not recruiting - Inguinal Hernia Clinical Trials

Evidence of Myogenic Growth Factors in 3D Dynamic Inguinal Hernia Scaffold ProFlor

HERNIA
Start date: January 1, 2013
Phase:
Study type: Observational

The study utilizes the same tissue specimens gathered for previous investigations and removed from 15 patients already operated for inguinal hernia, who for different reasons needed additional surgery in the previously operated groin.

NCT ID: NCT04912388 Active, not recruiting - Low Back Pain Clinical Trials

Serum Cytokine Levels in Patients With Lumbal Disc Herniation and Effectiveness of Exercise

Start date: July 30, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to investigate serum cytokine levels and the efficacy of lumbar stabilization exercises in patients with lumbar disc herniation with and without neurological deficits. Patients who applied to Hacettepe University Hospitals Physical Medicine and Rehabilitation Department with low back pain complaints and were referred for treatment will be included in the study.

NCT ID: NCT04634032 Active, not recruiting - Clinical trials for Genetic Predisposition to Disease

Gene Expression and DNA Variation Analysis of Sacs to Identify the Pathophysiology of Indirect Inguinal Hernia

Start date: October 22, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of the project is to show that gene expression levels change in at least one of the GATA6 and T-box transcription factor 3 (TBX3) genes in indirect inguinal hernia sacs, thus revealing that this pathway causes an error in the sac closure pathway. Indirect inguinal hernia is an important condition for human health as it is common in the community and can lead to life-threatening or permanent loss of function. In addition, since the treatment is performed surgically, the follow-up and treatment process of the patients should be managed carefully in terms of complications and costs. By explaining the mechanisms of the occurrence of this disease, important steps will be taken in terms of both human health and the development of science. Moreover, the data to be collected may open new horizons in the treatment of inguinal hernia. 20 inguinal hernia patients those consecutively applied to Trakya University Medical Faculty Department of Pediatric Surgery and 20 circumcision patients as control group will be included in the study.

NCT ID: NCT04626336 Active, not recruiting - Hernia Clinical Trials

Post-operative Hernias After Radical Cystectomy

Start date: January 30, 2010
Phase:
Study type: Observational

Post-operative hernias after cystectomy are frequent (our review of the literature with meta-analysis found an incidence of evisceration at 5%, median eventrations at 8% and peristomal hernias at 14%). These represent a non-negligible and partially morbidity. avoidable, subject to proper assessment of personal and surgical risk factors

NCT ID: NCT04534920 Active, not recruiting - Hernia Clinical Trials

Comparison of Sample Characteristics Between Subjects Who Received Strattice Mesh for Abdominal Wall Reconstruction

Start date: July 27, 2020
Phase:
Study type: Observational

Two different datasets from Institutional Review Board (IRB) approved studies L#12,083 and L#12,086 will be used to compare the sample characteristics between subjects who received Strattice mesh for abdominal wall reconstruction at Westchester Medical Center and Americas Hernia Society Quality Collaborative (AHSQC) registry.

NCT ID: NCT04437043 Active, not recruiting - Ventral Hernia Clinical Trials

A Multicenter Belgian Trial of Ventral Hernia Repair

UNITE
Start date: December 16, 2020
Phase: N/A
Study type: Interventional

Patients with incisional midline ventral hernias with a minimal width of 3 cm and a maximal width of 8 cm, treated according to the standard practice of the participating investigators. Patients can be treated with the following ventral hernia repair approaches: - Laparoscopic ventral hernia repair with closure of the defect (IPOM+) - Open ventral hernia repair with closure of the defect (retromuscular repair) - Robotic ventral hernia repair with closure of the defect (retromuscular repair) To evaluate the total number of days spent in the hospital within a period of 90 days post-operative. This will be calculated by adding the hospital length of stay for initial surgery or index-procedure, length of stay for any additional readmission resulting from the surgery or re-interventions, and emergency room visits resulting from the surgery or Serious Adverse Event (SAE) related to the index-procedure. Secondary objectives: To assess the safety, performance and efficacy of laparoscopic, open and robotic ventral hernia repair.